# Preoperative Twice Daily Chemoradiation in Addition to Chemotherapy Prior to Surgery in Stage III Non-Small Cell Lung Cancer (NSCLC)

> **NCT00176137** · PHASE3 · COMPLETED · sponsor: **Heidelberg University** · enrollment: 500 (—)

## Conditions studied

- Non-Small Cell Lung Cancer

## Interventions

- **PROCEDURE:** preoperative radiochemotherapy

## Key facts

- **NCT ID:** NCT00176137
- **Lead sponsor:** Heidelberg University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-10
- **Primary completion:** —
- **Final completion:** 2005-09
- **Target enrollment:** 500 (—)
- **Last updated:** 2008-04-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00176137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00176137, "Preoperative Twice Daily Chemoradiation in Addition to Chemotherapy Prior to Surgery in Stage III Non-Small Cell Lung Cancer (NSCLC)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00176137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*